Newstrike is a Canadian Cannabis company committed to growth.

1)      Growth. to help patients get the medicine they need produced to the quality standards they deserve.

2)      Growth of best-in-class supply, by applying our proprietary approach to increase capacity to identify, design, build and manage additional facilities to meet the evolving requirements of the Canadian market;

Publicly traded on the TSX-V under the symbol NR and federally licenced by Health Canada for cultivation through its proposed wholly owned subsidy Hemisphere Pharmaceuticals: Newstrike is committed to reliability, delivering long term value to our investors and growing responsibly.

For more information please sign up for updates


Investor Inquiries

Reach out to us directly, and a representative from Investor Relations will be in touch with shortly to answer your inquiry. 

Name *


Allan Rewak

Director, Communications & Stakeholder Relations

1 647 206 1231